Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2011 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

NOVATO, Calif., Nov. 9, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Ted Daley, President of Raptor will present an overview of...
October 25, 2011 14:11 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Holds Pre-NDA Meeting With FDA for RP103 for Nephropathic Cystinosis

NOVATO, Calif., Oct. 25, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced today that the Company concluded a pre-New Drug Application ("NDA")...
October 13, 2011 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the BioCentury NewsMakers Conference

NOVATO, Calif., Oct. 13, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Patrick Reichenberger, VP, Commercial Operations of Raptor...
September 22, 2011 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at JMP Securities Healthcare Conference

NOVATO, Calif., Sept. 22, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Christopher M. Starr, Ph.D., co-founder and Chief...
September 13, 2011 13:01 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Announces Closing of Public Offering of Common Stock

NOVATO, Calif., Sept. 13, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced the closing of its previously announced underwritten public...
September 08, 2011 09:29 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Announces Pricing of Public Offering of Common Stock

NOVATO, Calif., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced the pricing of its previously announced underwritten public...
September 07, 2011 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Announces Proposed Public Offering of Common Stock

NOVATO, Calif., Sept. 7, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that it intends to offer and sell shares of its common stock,...
July 25, 2011 21:22 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Host Conference Call and Webcast to Discuss Phase 3 Clinical Trial Results on Tuesday, July 26, 2011 at Noon EDT

NOVATO, Calif., July 25, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced today that they will host a conference call and webcast noon Eastern...
July 25, 2011 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Meets Primary Endpoint in Its Phase 3 Clinical Trial of DR Cysteamine for Nephropathic Cystinosis

NOVATO, Calif., July 25, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) today announced that its Phase 3 clinical trial of Delayed Release or DR...
July 06, 2011 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Receives Notices of Allowance for Two Key Patent Applications Protecting Its Cysteamine Portfolio

NOVATO, Calif., July 6, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that the United States Patent and Trademark Office ("USPTO") has...